As of May 27, 2025, Teladoc Health Inc's estimated intrinsic value ranges from $21.24 to $21.24 per share, depending on the valuation methodology applied.
Valuation Method | Fair Value (USD) | Implied Upside/Downside |
---|---|---|
Earnings Power Value | $21.24 | +211.9% |
Is Teladoc Health Inc (TDOC) undervalued or overvalued?
With the current market price at $6.81, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Teladoc Health Inc's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
WACC Component | Low | High |
---|---|---|
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.55 | 0.7 |
Cost of equity | 6.4% | 8.8% |
Cost of debt | 4.0% | 7.0% |
Tax rate | 0.6% | 5.0% |
Debt/Equity ratio | 1.29 | 1.29 |
After-tax WACC | 5.0% | 7.6% |
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
EPV Component | Value |
---|---|
Normalized Earnings | $246M |
Discount Rate (WACC) | 7.6% - 5.0% |
Enterprise Value | $3,251M - $4,895M |
Net Debt | $350M |
Equity Value | $2,902M - $4,545M |
Outstanding Shares | 175M |
Fair Value | $17 - $26 |
Selected Fair Value | $21.24 |
Metric | Value |
---|---|
Market Capitalization | $1194M |
Enterprise Value | $1543M |
Trailing P/E | 0.00 |
Forward P/E | 0.00 |
Trailing EV/EBITDA | 11.45 |
Current Dividend Yield | 0.00% |
Dividend Growth Rate (5Y) | 0.00% |
Debt-to-Equity Ratio | 1.29 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
Valuation Method | Weight | Weighted Value |
---|---|---|
Earnings Power Value | 100% | $2.12 |
Weighted Average | 100% | $21.24 |
Based on our comprehensive valuation analysis, Teladoc Health Inc's weighted average intrinsic value is $21.24, which is approximately 211.9% above the current market price of $6.81.
Key investment considerations:
Given these factors, we believe Teladoc Health Inc is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.